Clinical trial · Observational
Construction of Gynecological Tumor Organoids
NCT06155370CI-TRIAL-00071920unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study focuses on the construction of a biological sample library for organoids and tumor tissues in gynecological tumors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynecologic Cancer | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
| Organoid | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| construction of organoids from gynecological tumor | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (6)
- label
- cohort of cervical cancer organoids
- description
- organoids derived from cervical cancer
- interventionNames
- Other: construction of organoids from gynecological tumor
- label
- cohort of endometrial cancer organoids
- description
- organoids derived from endometrial cancer
- interventionNames
- Other: construction of organoids from gynecological tumor
- label
- cohort of ovarian cancer organoids
- description
- organoids derived from ovarian cancer
- interventionNames
- Other: construction of organoids from gynecological tumor
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age of 18 or older, an informed consent form is provided; 2. The preoperative tumor burden assessment and intraoperative researcher team believe that sampling is feasible; 3. Having relevant requirements for sample library storage; 4. Surgical treatment at Peking Union Medical College Hospital. Exclusion Criteria: 1. Unable to meet all inclusion criteria; 2. The research team considers any situations or considerations that may hinder normal pathological assessment.
References
Publications (0)
Data not yet available
No reference posted for this study.